HAMBORNER REIT AG NA O.N./ DE000A3H2333 /
| 2024-05-23 1:05:04 PM | Chg. -0.030 | Volume | Bid1:05:10 PM | Ask1:05:10 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.530EUR | -0.46% | 600 Turnover: 3,942 |
6.540Bid Size: 800 | 6.570Ask Size: 800 | 530.36 mill.EUR | 7.36% | - |
GlobeNewswire
1:17 PM
CAE, Inc. Falls Over 13% at Open on Impairment Charges, BFA Law Encourages Investors to Contact the ...
GlobeNewswire
1:03 PM
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor...
GlobeNewswire
1:00 PM
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
1:00 PM
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform
GlobeNewswire
1:00 PM
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
GlobeNewswire
1:00 PM
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offer...
GlobeNewswire
1:00 PM
Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nomin...
GlobeNewswire
1:00 PM
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA...
GlobeNewswire
1:00 PM
Pyro Green-Gas Signs Contracts Totaling $1.3 Million with Global Steel Company to Desulphurize Coke ...
GlobeNewswire
1:00 PM
Immersive Fishing and Boating Sim ‘Ships at Sea’ from Misc Games Available Now in PC Early Access
GlobeNewswire
1:00 PM
Sandy Spring Bancorp’s Board of Directors Appoints Charles S. Cullum Chief Financial Officer
GlobeNewswire
1:00 PM
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
